Clinical trial
PS-341 in Treating Patients With Metastatic Kidney Cancer
NCT00025376 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00025376 |
|---|---|
| Title | PS-341 in Treating Patients With Metastatic Kidney Cancer |
| Official title | A Phase II Trial of PS-341 in Patients With Renal Cell Cancer |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug, Procedure |
| Interventions | PS-341, Tumor Biopsy |
| Enrollment | 23 |
| Start date | Oct 1, 2001 |
| Primary completion | Sep 1, 2002 |
| Completion | Mar 1, 2006 |
| First posted | Jun 17, 2003 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: